期刊文献+

左氧氟沙星及力克菲蒺治疗耐多药肺结核病的疗效观察 被引量:7

The clinical observation on the efficacy of the short-term with levofloxacin and pasiniazide in the treatment of multi-drug resistant pulmonary tuberculosis
下载PDF
导出
摘要 目的观察含左氧氟沙星和力克菲蒺的化疗方案在治疗耐多药肺结核病的疗效。方法将98例耐多药肺结核分为治疗组50例和对照组48例,治疗组以左氧氟沙星和力克菲蒺为主,联合丁胺卡那霉素、利福喷丁、丙硫异烟胺;对照组用丁胺卡那霉素、利福喷丁、丙硫异烟胺、吡嗪酰胺及乙胺丁醇,疗程均为21个月。结果疗程结束后,治疗组痰菌阴转率、空洞闭合率及病灶吸收好转率分别为82%、77.5%及84%,对照组则分别为56.3%、54.3%及52.1%,两组比较差异显著(分别为P<0.01,P<0.05及P<0.005);两组的不良反应分别为30%及27.1%,差异无显著性(P>0.05)。结论含左氧氟沙星及力克菲蒺的方案治疗耐多药肺结核安全有效,值得推广应用。 Objective To study and observe the clinical efficacy of a combined therapy of levofloxacin (LVFX), pasiniazide (Pa) and other antituberculosis drugs in the treatment of multi-drug resistant pulmonary tuberculosis (MDR-TB). Methods 98 patients with MDR-TB were assigned to a study group (50 cases), treated with LVFX, Pa, amikacin (AK), rafapentine (RFT) and prothionadam (1321TH), and a control group (48 cases), treated with AK, RFT, 1321TH, ethambutol (EMB) and pyrazinamide (PZA). The course of treatment was 21 months. Results When the course was completed, the sputum negative conversion rate, the closure rate of the lung cavities and the radiographic resolution rate in the study group were 82%, 77.5% and 84%, respectively, which were higher than that in the controls (56.3%, 54.3% and 52.1% respectively) : P〈0.01, 0.05 and 0. 005 respectively. And no significant difference was found in side-effects between the two groups (30% in the study group, and 27.1% in the control group) : P〉0. 05. Conclusion The scheme including levofloxacin and pasiniazide was effective and safe for the patients with MDR-TB.
作者 王莉
出处 《临床肺科杂志》 2006年第1期24-25,共2页 Journal of Clinical Pulmonary Medicine
关键词 结核 耐多种药物性 药物疗法 治疗效果 Tuberculosis pulmonary multidrug-resisent drug therapy therapeutic effect
  • 相关文献

参考文献5

二级参考文献22

  • 1何国钧.抗结核药物的研究进展[J].中国防痨杂志,1996,18(3):136-139. 被引量:47
  • 2Mukund Uplekar 肖和平等(译).结核病临床手册[M].上海:复旦大学出版社,1999.50-54.
  • 3John Crofton Norman Horne Fred Miller(王撷秀 屠德华 安燕生译).临床结核病:第2版[M].北京:科学出版社,2000.160~162.
  • 4肖和平 何国钧.结核分支杆菌感染[A].见:汪复主编.抗感染药物临床应用手册[C].北京:人民卫生出版社,2001.102~106.
  • 5John Crofton Pierre Chaulet Dermot Maker(肖和平 杨敏译).耐药结核病处理指南[M].上海:卫生部结核病控制分中心,1997.4~41.
  • 6陈新谦 金有豫 编.新编药物学:第12版[M].北京:人民卫生出版社,1988.130~136.
  • 7肖和平.肺结核诊治进展[A].见:黄绍光主编.肺内科新进展[C].北京:人民卫生出版社,2000.178~201.
  • 8中华人民共和国卫生部疾病控制司.中国结核病防治规划实施工作指南[M].北京:中华人民共和国卫生部,2002.6-34.
  • 9肖和平 何国钧.耐多药结核病诊断与处理的研讨[J].中国防痨杂志,1999,21:21-22.
  • 10中华人民共和国卫生部疾病控制司 卫生部医政司.全国结核病防治工作手册[M].北京,1999.52~61.

共引文献517

同被引文献39

引证文献7

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部